IMPACT STORY 8
Can we differentiate in a crowded market – and still deliver first-in-class access?”
A Rheumatoid Arthritis product needed to break through an evidence-rich and crowded therapeutic landscape.
A forward-looking access plan combined unmet need framing, dynamic HEOR models, and value story integration to secure first-in-class HTA positioning.
The Result
The approach enabled successful approval, market access, and positioning aligned with the client’s short and long term commercial strategy
Linked Service Line
Early Access Strategy / HEOR Communications
Linked Disease Area
Immunology (Rheumatoid Arthritis)
Linked Product Lifecycle Stage
Early Market Access / Launch